Published on: 08/27/2026
This news was posted by Oregon Today News
Description

The U.S. Food and Drug Administration has approved the first oral medicine designed to treat adults with dermatomyositis, a rare and debilitating autoimmune condition that attacks the muscles and skin.
Other Related News
08/27/2026
The lawsuit names Washington and governing boards for UW WSU and other public colleges as ...
08/27/2026
Timothy Ray Jones faces over six years in prison after targeting over 30 Plaid Pantry stor...
08/27/2026
Gunfire was reported at a homeless camp at Wallace Marine Park where police found a 60-yea...
08/27/2026
82726 - Sheriffs Office SAR helps Rescue person stuck on Mt Yoran On August 26th a littl...
08/27/2026
